Reaching Out to Distressed Medical Residents, Fellows and Faculty
The purpose of this study is to study whether distressed medical residents, fellows, and faculty health professionals benefit from completing online an anonymous and interactive screening of stress, depression, substance use, and suicidal thoughts. The screening and ability to interact online with a clinician anonymously are hypothesized to increase willingness to come for counseling in person. Suicide risk factors are expected to be lower once the distressed medical trainee or faculty member receives treatment.
Conditions studied
Depression, Suicide
About this study
The purpose of this study is to study whether distressed medical residents, fellows, and faculty health professionals benefit from completing online an anonymous and interactive screening of stress, depression, substance use, and suicidal thoughts. The screening and ability to interact online with a clinician anonymously are hypothesized to increase willingness to come for counseling in person. Suicide risk factors are expected to be lower once the distressed medical trainee or faculty member receives treatment.
Interventions
- Behavioral: counseling — in-person counseling through RFWP offered to distressed respondents on the ISP and others who seek counseling (due to other reasons for referral)
Primary outcomes
- ISP levels of distress seen with medical trainees and faculty (Time survey is completed by trainee or faculty member at baseline)
- Demographics of residents and faculty physicians who seek counseling through in house program (at enrollment for treatment (intake appointment))
- Who responds to treatment--level of distress (time of intake (baseline) to participants' end of treatment or 6 months since last seen)
- Who responds to treatment-level of burnout (time of intake to participants' end of treatment or 6 months since last seen)
- Who responds to treatment-clinician rating of suicide risk (time of intake (baseline) to participants end of treatment or 6 months since last seen)
Eligibility information
Study locations
- Oregon Health and Science University, Portland, Oregon 97239 United States
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.